Gadopentetate dimeglumine Pregnancy and Breastfeeding Warnings
Gadopentetate dimeglumine is also known as: Magnevist
Medically reviewed on January 2, 2018
Gadopentetate dimeglumine Pregnancy Warnings
Gadopentetate dimeglumine has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadopentetate dimeglumine is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Gadopentetate dimeglumine Breastfeeding Warnings
Gadopentetate dimeglumine is excreted into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadopentetate dimeglumine to nursing women.
References for pregnancy information
- "Product Information. Magnevist (gadopentetate dimeglumine)." Berlex Laboratories, Wayne, NJ.
References for breastfeeding information
- "Product Information. Magnevist (gadopentetate dimeglumine)." Berlex Laboratories, Wayne, NJ.
See Also...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
